253 related articles for article (PubMed ID: 15663483)
21. Wild-type Cu/Zn superoxide dismutase (SOD1) does not facilitate, but impedes the formation of protein aggregates of amyotrophic lateral sclerosis causing mutant SOD1.
Witan H; Gorlovoy P; Kaya AM; Koziollek-Drechsler I; Neumann H; Behl C; Clement AM
Neurobiol Dis; 2009 Nov; 36(2):331-42. PubMed ID: 19660548
[TBL] [Abstract][Full Text] [Related]
22. Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.
Wang H; Yang B; Qiu L; Yang C; Kramer J; Su Q; Guo Y; Brown RH; Gao G; Xu Z
Hum Mol Genet; 2014 Feb; 23(3):668-81. PubMed ID: 24108104
[TBL] [Abstract][Full Text] [Related]
23. Intracellular conformational alterations of mutant SOD1 and the implications for fALS-associated SOD1 mutant induced motor neuron cell death.
Zhang F; Zhu H
Biochim Biophys Acta; 2006 Mar; 1760(3):404-14. PubMed ID: 16431026
[TBL] [Abstract][Full Text] [Related]
24. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice.
Towne C; Raoul C; Schneider BL; Aebischer P
Mol Ther; 2008 Jun; 16(6):1018-25. PubMed ID: 18414477
[TBL] [Abstract][Full Text] [Related]
25. Familial amyotrophic lateral sclerosis-linked mutant SOD1 aberrantly interacts with tubulin.
Kabuta T; Kinugawa A; Tsuchiya Y; Kabuta C; Setsuie R; Tateno M; Araki T; Wada K
Biochem Biophys Res Commun; 2009 Sep; 387(1):121-6. PubMed ID: 19576169
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression.
Wang H; Ghosh A; Baigude H; Yang CS; Qiu L; Xia X; Zhou H; Rana TM; Xu Z
J Biol Chem; 2008 Jun; 283(23):15845-52. PubMed ID: 18367449
[TBL] [Abstract][Full Text] [Related]
27. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.
Raoul C; Abbas-Terki T; Bensadoun JC; Guillot S; Haase G; Szulc J; Henderson CE; Aebischer P
Nat Med; 2005 Apr; 11(4):423-8. PubMed ID: 15768028
[TBL] [Abstract][Full Text] [Related]
28. Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression.
Lu L; Zheng L; Viera L; Suswam E; Li Y; Li X; Estévez AG; King PH
J Neurosci; 2007 Jul; 27(30):7929-38. PubMed ID: 17652584
[TBL] [Abstract][Full Text] [Related]
29. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
Zimmerman MC; Oberley LW; Flanagan SW
J Neurochem; 2007 Aug; 102(3):609-18. PubMed ID: 17394531
[TBL] [Abstract][Full Text] [Related]
30. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis.
Basso M; Pozzi S; Tortarolo M; Fiordaliso F; Bisighini C; Pasetto L; Spaltro G; Lidonnici D; Gensano F; Battaglia E; Bendotti C; Bonetto V
J Biol Chem; 2013 May; 288(22):15699-711. PubMed ID: 23592792
[TBL] [Abstract][Full Text] [Related]
31. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
Hayashi Y; Homma K; Ichijo H
Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
[TBL] [Abstract][Full Text] [Related]
32. [RNAi and neurological disease].
Yokota T
Rinsho Shinkeigaku; 2005 Nov; 45(11):973-5. PubMed ID: 16447777
[TBL] [Abstract][Full Text] [Related]
33. Mutant SOD1 instability: implications for toxicity in amyotrophic lateral sclerosis.
Tiwari A; Hayward LJ
Neurodegener Dis; 2005; 2(3-4):115-27. PubMed ID: 16909016
[TBL] [Abstract][Full Text] [Related]
34. HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS.
Zhai J; Lin H; Canete-Soler R; Schlaepfer WW
Hum Mol Genet; 2005 Sep; 14(18):2629-40. PubMed ID: 16079151
[TBL] [Abstract][Full Text] [Related]
35. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?
Kabashi E; Valdmanis PN; Dion P; Rouleau GA
Ann Neurol; 2007 Dec; 62(6):553-9. PubMed ID: 18074357
[TBL] [Abstract][Full Text] [Related]
36. ALS-causing SOD1 mutations promote production of copper-deficient misfolded species.
Ip P; Mulligan VK; Chakrabartty A
J Mol Biol; 2011 Jun; 409(5):839-52. PubMed ID: 21549128
[TBL] [Abstract][Full Text] [Related]
37. [Implications of successful immunotherapy in ALS model mice].
Urushitani M
Brain Nerve; 2008 Jun; 60(6):643-51. PubMed ID: 18567360
[TBL] [Abstract][Full Text] [Related]
38. Design of functional small interfering RNAs targeting amyotrophic lateral sclerosis-associated mutant alleles.
Geng CM; Ding HL
Chin Med J (Engl); 2011 Jan; 124(1):106-10. PubMed ID: 21362317
[TBL] [Abstract][Full Text] [Related]
39. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
[TBL] [Abstract][Full Text] [Related]
40. Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis.
Watanabe S; Nagano S; Duce J; Kiaei M; Li QX; Tucker SM; Tiwari A; Brown RH; Beal MF; Hayward LJ; Culotta VC; Yoshihara S; Sakoda S; Bush AI
Free Radic Biol Med; 2007 May; 42(10):1534-42. PubMed ID: 17448900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
